This may be due to the fact that p53 was not restored in all tumor cells, except in hepatocarcinomas that completely regressed (Xue et al., 2007) or that other mechanisms dampen p53 restoration (high Mdm2 or mutant p53 with dominant-negative GOF activities). The gene discussed is MDM2; the disease is neoplasm.